Hasegawa S - Search Results

1

Clinical evaluation of CYFRA 21-1 in malignant pleural fluids.

Satoh H, Sumi M, Yagyu H, Ishikawa H, Suyama T, Naitoh T, Saitoh T, Hasegawa S. Satoh H, et al. Among authors: hasegawa s. Oncology. 1995 May-Jun;52(3):211-4. doi: 10.1159/000227459. Oncology. 1995. PMID: 7536317

2

Elevated sialyl Lewis X-i antigen levels in pleural effusions in patients with carcinomatous pleuritis.

Ishikawa H, Satoh H, Kamma H, Naito T, Yamashita YT, Ohtsuka M, Hasegawa S. Ishikawa H, et al. Among authors: hasegawa s. Intern Med. 1997 Oct;36(10):685-9. doi: 10.2169/internalmedicine.36.685. Intern Med. 1997. PMID: 9372327 Free article.

3

[Clinical significance of cytokine measurement in pleural effusion].

Naito T, Ohtsuka M, Ishikawa H, Satoh H, Hasegawa S. Naito T, et al. Among authors: hasegawa s. Kekkaku. 1997 Oct;72(10):565-72. Kekkaku. 1997. PMID: 9386355 Japanese.

4

Long-term cure of a malignant lymphoma of the pleural cavity treated by irradiation.

Sumi M, Satoh H, Ohtsuka M, Hasegawa S, Fujiwara M, Kamma H. Sumi M, et al. Among authors: hasegawa s. Oncol Rep. 1998 Nov-Dec;5(6):1439-40. doi: 10.3892/or.5.6.1439. Oncol Rep. 1998. PMID: 9769383

5

Production of cytokeratin 19 fragment by human squamous lung cancer cell lines.

Satoh H, Ishikawa H, Fujiwara M, Yamashita YT, Ohtsuka M, Ogata T, Hasegawa S, Kamma H. Satoh H, et al. Among authors: hasegawa s. Am J Respir Cell Mol Biol. 1997 May;16(5):597-604. doi: 10.1165/ajrcmb.16.5.9160842. Am J Respir Cell Mol Biol. 1997. PMID: 9160842

6

Urokinase-type plasminogen activator in carcinomatous pleural fluid.

Ishikawa H, Satoh H, Hasegawa S, Yazawa T, Naito T, Yamashita YT, Ohtsuka M, Ogata T, Kamma H. Ishikawa H, et al. Among authors: hasegawa s. Eur Respir J. 1997 Jul;10(7):1566-71. doi: 10.1183/09031936.97.10071566. Eur Respir J. 1997. PMID: 9230248 Free article.

7

The effect of TNP-470 on cell proliferation and urokinase-type plasminogen activator and its inhibitor in human lung cancer cell lines.

Ishikawa H, Satoh H, Kamma H, Naito T, Ohtsuka M, Ogata T, Hasegawa S. Ishikawa H, et al. Among authors: hasegawa s. J Exp Ther Oncol. 1996 Nov;1(6):390-6. J Exp Ther Oncol. 1996. PMID: 9414430

8

Pleural effusion as a significant prognostic factor in non-small cell lung cancer.

Naito T, Satoh H, Ishikawa H, Yamashita YT, Kamma H, Takahashi H, Ohtsuka M, Hasegawa S. Naito T, et al. Among authors: hasegawa s. Anticancer Res. 1997 Nov-Dec;17(6D):4743-6. Anticancer Res. 1997. PMID: 9494600

9

[Lymphocyte chemotactic factor in tuberculous pleural effusion].

Naito T, Ohtsuka M, Ishikawa H, Satoh H, Hasegawa S. Naito T, et al. Among authors: hasegawa s. Kekkaku. 1998 Apr;73(4):307-14. Kekkaku. 1998. PMID: 9613051 Japanese.

10

Curved chest tube for drainage of malignant pleural effusion.

Ishikawa H, Satoh H, Yamashita YT, Kamma H, Naito T, Ohtsuka M, Hasegawa S. Ishikawa H, et al. Among authors: hasegawa s. Respir Med. 1998 Apr;92(4):633-7. doi: 10.1016/s0954-6111(98)90509-1. Respir Med. 1998. PMID: 9659528 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,113 results

Search Page

Filters